Ibere Pharmaceuticals

Entity
Company
Industry
Blank Checks (Office Of Real Estate & Construction)
Business address
2005 Market Street, Suite 2030, 19103 Philadelphia, PA
Phone
267-765-3222
State of incorporation
Cayman Islands
Fiscal year end
December 31
Category

Emerging growth company
All SEC filings
View on sec.gov
Ibere Pharmaceuticals has filed 51 SEC EDGAR filings since 12/7/2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
15-12G Open Document Open Filing 15-12G Mar 13, 2023 001-40119
25-NSE Open Document Open Filing Mar 2, 2023 001-40119
8-K Open Document | Data Open Filing FORM 8-K Feb 15, 2023 Feb 15, 2023 001-40119
SC 13G Open Document Open Filing Feb 14, 2023 005-92346
SC 13G/A Open Document Open Filing SC 13G/A Feb 14, 2023 005-92346
SC 13G Open Document Open Filing IBER 13G Feb 8, 2023 005-92346
SC 13G/A Open Document Open Filing SCHEDULE 13G (AMENDMENT NO. 1) Feb 8, 2023 005-92346
SC 13G/A Open Document Open Filing SC 13G/A Feb 2, 2023 005-92346
10-Q Open Document | Data Open Filing 10-Q Nov 14, 2022 Sep 30, 2022 001-40119
10-Q Open Document | Data Open Filing 10-Q Aug 12, 2022 Jun 30, 2022 001-40119
10-Q Open Document | Data Open Filing 10-Q May 16, 2022 Mar 31, 2022 001-40119
10-K Open Document | Data Open Filing 10-K Mar 31, 2022 Dec 31, 2021 001-40119
SC 13G/A Open Document Open Filing IBERE PHARMACEUTICALS Feb 14, 2022 005-92346
SC 13G Open Document Open Filing SC 13G Feb 8, 2022 005-92346
SC 13G Open Document Open Filing SCHEDULE 13G Jan 14, 2022 005-92346
10-Q Open Document | Data Open Filing FORM 10-Q Nov 12, 2021 Sep 30, 2021 001-40119
SC 13G Open Document Open Filing SCHEDULE 13G Sep 27, 2021 005-92346
10-Q Open Document | Data Open Filing FORM 10-Q Aug 16, 2021 Jun 30, 2021 001-40119
10-Q/A Open Document | Data Open Filing 10-Q/A Aug 16, 2021 Mar 31, 2021 001-40119
8-K/A Open Document Open Filing FORM 8-K/A Aug 16, 2021 Mar 2, 2021 001-40119
8-K Open Document Open Filing FORM 8-K Aug 13, 2021 Aug 10, 2021 001-40119
8-K Open Document Open Filing FORM 8-K Aug 4, 2021 Jul 29, 2021 001-40119
10-Q Open Document | Data Open Filing FORM 10-Q Jul 16, 2021 Mar 31, 2021 001-40119
8-K Open Document Open Filing FORM 8-K May 28, 2021 May 25, 2021 001-40119
NT 10-Q Open Document Open Filing NT 10-Q May 18, 2021 Mar 31, 2021 001-40119
SC 13G Open Document Open Filing SC 13G Mar 12, 2021 005-92346
8-K Open Document Open Filing FORM 8-K Mar 8, 2021 Mar 2, 2021 001-40119
8-K Open Document Open Filing FORM 8-K Mar 3, 2021 Feb 25, 2021 001-40119
4 Open Document Open Filing OWNERSHIP DOCUMENT Mar 2, 2021 Mar 2, 2021
424B4 Open Document Open Filing 424B4 Mar 1, 2021 333-252863
EFFECT Open Document Open Filing Feb 25, 2021 333-252863
3 Open Document Open Filing OWNERSHIP DOCUMENT Feb 25, 2021 Feb 25, 2021
3 Open Document Open Filing OWNERSHIP DOCUMENT Feb 25, 2021 Feb 25, 2021
3 Open Document Open Filing OWNERSHIP DOCUMENT Feb 25, 2021 Feb 25, 2021
3 Open Document Open Filing OWNERSHIP DOCUMENT Feb 25, 2021 Feb 25, 2021
3 Open Document Open Filing OWNERSHIP DOCUMENT Feb 25, 2021 Feb 25, 2021
3 Open Document Open Filing OWNERSHIP DOCUMENT Feb 25, 2021 Feb 25, 2021
3 Open Document Open Filing OWNERSHIP DOCUMENT Feb 25, 2021 Feb 25, 2021
3 Open Document Open Filing OWNERSHIP DOCUMENT Feb 25, 2021 Feb 25, 2021
S-1MEF Open Document Open Filing S-1MEF Feb 25, 2021 333-253552
CERT Open Document Open Filing NYSE CERTIFICATION Feb 25, 2021 001-40119
8-A12B Open Document Open Filing FORM 8-A12B Feb 25, 2021 001-40119
CORRESP Open Document Open Filing Feb 24, 2021
CORRESP Open Document Open Filing Feb 24, 2021
CORRESP Open Document Open Filing Feb 22, 2021
S-1/A Open Document Open Filing FORM S-1/A Feb 22, 2021 333-252863
S-1 Open Document Open Filing FORM S-1 Feb 9, 2021 333-252863
CORRESP Open Document Open Filing Feb 8, 2021
UPLOAD Open Document Open Filing Dec 31, 2020
DRSLTR Open Document Open Filing Dec 7, 2020
DRS Open Document Open Filing Dec 7, 2020 377-03858